Dead and dying cancer cells killed by conventional cancer treatments paradoxically trigger inflammation that promotes tumor growth and metastasis. Researchers now describe a novel approach to suppressing chemotherapy-induced tumor growth in an ovarian cancer model.
Surge protector: A novel approach to suppressing therapy-induced tumor growth and recurrence
Dead and dying cancer cells killed by conventional cancer treatments paradoxically trigger inflammation that promotes tumor growth and metastasis. Researchers now describe a novel approach to suppressing chemotherapy-induced tumor growth in an ovarian cancer model.